Printer Friendly

Use of intravenous dexmedetomidine in modified radical mastoidectomy under general anesthesia.

INTRODUCTION

Modified radical mastoidectomy is the surgery of choice in most patients suffering from chronic suppurative otitis media. It is usually done under general anesthesia. Patient and surgeon both are comfortable under general anesthesia. It has been observed that bleeding is more at the surgical site under general anesthesia. The pressor response, which is part of the huge spectrum of stress response, results from the increase in sympathetic and sympathoadrenal activity, as evidenced by increased plasma catecholamines concentration in patients undergoing surgery under general anesthesia (GA).[1-5] Sometimes blood loss is troublesome, interfere with surgical flied so controlled hypotension is requested by surgeon. Generally, nitroglycerine is used for controlled hypotension.

Dexmedetomidine is the most recently released intravenous (i.v.) Anesthetic. It is a highly selective [[alpha].sub.2]-adrenoceptor agonist that produces sedation, sympatholysis, hypnosis, and analgesia. It has minimal effect on respiration. Heart rate (HR) and cardiac output show a concentration-dependent decrease.[6]

The aim of this study is to evaluate the efficacy of dexmedetomidine on the reduction of intraoperative bleeding in modified radical mastoidectomy under general anesthesia.

MATERIALS AND METHODS

This prospective, randomized; double-blind controlled trial was approved by hospital ethical committee. After taking informed consent, 100 patients of ASA Grade I and II aged between 20 and 50 years, scheduled for modified radical mastoidectomy under general anesthesia were selected. Pregnant and nursing women are not included in this study. Patients with a history of cardiovascular disease and history of allergy to any of the study medication are also not included.

The research methodology was prospectively randomized with the help of computer-generated coded envelops and patients were divided into two groups (n = 50); Group D and Group C. Dexmedetomidine was administrated to Group D first as a loading dose of 1 [micro]g/kg and then intraoperative maintenance with dexmedetomidine 0.5 [micro]g/kg/hr. Group C (control group) was given the identical amount of saline. All drugs were prepared by an anesthesiologists not involved with the study to keep the study investigator blinded.

All patients were fasted for 8 h in the pre-operative room; glycopyrrolate 0.2 mg i.m. was administrated as premedication. A good i.v. access was secured, and baseline parameters were observed and recorded, which included HR, mean arterial blood pressure (MAP), electrocardiogram, respiratory rate, and pulse oximetry. Thereafter, Group C received 100 ml of normal saline for 20 min. While Group D received 1 [micro]g/kg of dexmedetomidine in 100 ml of normal saline over 20 min and 2 [micro]g/kg of Fentanyl 3 min before the induction of anesthesia. The patient was preoxygenated with 100% [O.sub.2] for 3 min, and anesthesia was induced by propofol 2 mg/kg Succinylcholine 100 mg i.v. was administrated as the muscle relaxant for intubation and orotracheal intubation done with appropriate size ETT. Anesthesia was maintained with isoflurane 0.8-1% and nitrous oxide 70% in [O.sub.2] 30%. Muscle relaxation was achieved by injection atracurium 0.4 mg/kg i.v. and maintained by injection atracurium 0.08 mg/kg i.v. Group C received normal saline, and Group D received dexmedetomidine 0.5 [micro]m/kg/h for maintenance.

The heart rate and MAP were recorded at 3 min intervals during the surgery. The bleeding during the operation was observed by the surgeon and intraoperative grading as follows:

* 0 = No bleeding--excellent surgical condition;

* 1 = Minimum bleeding and sporadic suction;

* 2 = Diffuse bleeding and repeated suction;

* 3 = Considerable, troublesome bleeding, and continuous suction.

When there is diffuse bleeding and repeated suction is required, surgeon is requested of controlled hypotension, then we use nitroglycerin for controlled hypotension. In each group, how much patients are required nitroglycerin, is noted.

At the end of the surgical procedure, reversal had done with neostigmine 2.5 mg and glycopyrrolate 0.5 mg intravenously. Extubation was carried out as routine procedure and patients were shifted to the recovery ward for further observation.

Unpaired student i-test and Chi-square test were used for analyzing the data. P < 0.05 was considered statistically significant.

RESULTS

Patient's age, weight, and ASA physical status are presented in Table 1. There were no significant differences in patient's characteristics among the groups.

The number of patients who required nitroglycerin for reduction of bleeding in each group is shown in Table 2.

No patient in Group D required nitroglycerin for reduction of bleeding, but 40 patients in Group C required nitroglycerin for reduction of bleeding.

Bleeding during the operation as assessed by the surgeon is shown in Table 3.

The overall incidence of significant bleeding which required frequent suctioning in control group was 40 (80%) compared with 0 (0%) in the Group D.

DISCUSSION

Our investigation indicates that use of i.v. dexmedetomidine reduces intraoperative bleeding at the surgical site in modified radical mastoidectomy under general anesthesia. In control group, most of the patients require nitroglycerin for reduction of bleeding, but no patients in Group D require nitroglycerin.

In our study, no patients in dexmedetomidine group required nitroglycerin for controlled hypotension while 40 patients in control gp required nitroglycerin for controlled hypotension. Another study was carried out by Durmus et al. for evaluating the efficacy of dexmedetomidine on bleeding during tympanoplasty or septoplasty.[6] They concluded that dexmedetomidine is a useful adjuvant to decrease bleeding when a bloodless surgical is requested.

A study conducted by Ayoglu et al. concluded that dexmedetomidine reduces bleeding, bleeding scores, and intraoperative fentanyl consumption during GA in septoplasty operation.[7] In our study also patients of dexmedetomidine group are having no and minimum bleeding and patients of the control group are having diffuse and considerable bleeding.

In our study, we used dexmedetomidine for controlled hypotension. In another study conducted by Tobias and Berkenbosch also concluded that dexmedetomidine can be used for controlled hypotension in spinal surgery.[8]

In the present study, surgical field is better in Group D. This result is supported by various other studies conducted by Nasreen et al.,[9] Gupta et al.,[10] and Chiruvella et al.[11] they concluded that patients receiving dexmedetomidine infusion had a better surgical field. These findings can be attributed to the fact that dexmedetomidine is the highly selective [[alpha].sub.2]-adrenoceptor agonist that produces sedation, sympatholysis, hypnosis, and analgesia. Heart rate and cardiac output show a concentration-dependent decrease[12] so that providing better surgical field.

Only few studies are carried out on use of dexmedetomidine infusion for control of intraoperative bleeding. Hence, this study having large number of patients provides useful data for guiding future studies. Limitation of this study is that we just observed bleeding at the surgical site and depends on surgeons for scoring.

Due to its central sympatholytic effect, dexmedetomidine is useful in blunting hemodynamic responses in perioperative period. It is successfully used in i.v. doses varying from 0.25 to 1 mcg/kg for attenuating intubation response.[13-16] The optimal dose for attenuating pressor response seemed to be 1 mcg/kg with lesser doses not being effective.[16] Infusion continued into the post-operative period has been associated with reduced hemodynamic fluctuations and decrease in plasma catecholamines.[14] Different characteristics of the dexmedetomidine provide better hemodynamic profile thus reduces intraoperative bleeding.

CONCLUSION

Infusion of dexmedetomidine in a perioperative period significantly reduced the requirement of nitroglycerin for controlled hypotension. The dexmedetomidine is a useful adjuvant to decrease bleeding when a bloodless surgical field is requested by surgeons.

REFERENCES

[1.] Sturaitis M, Kroin J, Swamidoss C, Moric M. Effects of intraoperative Dexmedetomidine infusion of hemodynamic stability during tumor resection. Anaesthesiology 2002; 98:A-310.

[2.] Bekkar A, Basile J, Gold M, Riles T, Adelman M, Cuff G, et al. Dexmedetomidine for awake carotid endarterectomy. Efficacy, hemodynamic profile, and side effects. J Neurosurg Anesth 2004; 16:126-36.

[3.] Reich DL, Hossain S, Krol M, Baez B, Patel P, Bernstein A, et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 2005; 101:622-8, table of contents.

[4.] Wijeysuasundera DN, Naik JS, Beattie WS. [[alpha].sub.2] adrenoceptor-agonist to prevent perioperative cardiovascular complications: A meta-analysis. Am J Med 2003; 114:742-52.

[5.] Yildiz M, Tavlan A, Tuncer S, Reisli R, Yosunkaya A, Otelcioglu S. Effect of Dexmedetomidine on haemodyanamic responses to laryngoscopy and intubation: Perioperative haemodynamics and anesthetic requirements. Drugs R D 2006;7:43-52.

[6.] Durmus M, But AK, Dogan Z, Yucel A, Miman MC, Ersoy MO, et al. Effect of dexmedetomidine on bleeding during tympanoplasty or septorhinoplasty. Eur J Anaesthesiol 2007;24:447-53.

[7.] Ayoglu H, Yapakci O, Ugur MB, Uzun L, Altunkaya H, Ozer Y, et al. Effectiveness of dexmedetomidine in reducing bleeding during septoplasty and tympanoplasty operations. J Clin Anesth 2008; 20:437-41.

[8.] Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002; 12:171-5.

[9.] Nasreen F, Bano S, Khan RM, Hasan SA. Dexmedetomidine used to provide hypotensive anesthesia during middle ear surgery. Indian J Otolaryngol Head Neck Surg 2009; 61:205-7.

[10.] Gupta K, Bansal M, Gupta PK, Pandey M, Agarwal S. Dexmedetomidine infusion during middle ear surgery under general anaesthesia to provide oligaemic surgical field: A prospective study. Indian J Anaesth 2015; 59:26-30.

[11.] Chiruvella S, Donthu B, Venkata SJ. Controlled hypotensive anaesthesia wtih Dexmedetomidine for functional endoscopic sinus surgery. J Evol Med Dent Sci 2014;3: 9556-63.

[12.] Miller RD. Miller's Anesthesia. 8th ed. Philadelphia, PA: Churchill Livingstone; 2015. P. 822.

[13.] BC, Ward DS, Belleville JP, Maze M. Effects of intravenous Dexmedetomidine in humans, II: Hemodynamic changes. Anesthesialogy 1992;77:1134-42.

[14.] Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.

[15.] Bekker A, Sturaitis M, Bloom M, Moric M, Golfinos J, Parker E, et al. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg 2008;107:1340-7.

[16.] Sagiroglu AE, Celik M, Yuzer SO, Sen B. Different doses of Dexmedetomidine on controlling hemodynamic responses to tracheal intubation. Int J Anesthesiol 2010;27:2.

Sarita Gohiya, Vineet Kumar Gohiya

Department of Anesthesia, Government Medical College, Khandwa, Madhya Pradesh, India

Correspondence to: Sarita Gohiya, E-mail: drsgohiya@gmail.com

Received: April 18, 2018; Accepted: May 03, 2018

DOI: 10.5455/ijmsph.2018.0413403052018
Table 1: Demographic data (Mean[+ or -]SD)

Parameter     Control group      Group D

Age (years)   30[+ or -]8.1   31[+ or -]7.7
Weight (kg)   50[+ or -]7.2   52[+ or -]7.2
ASA I/II          35/15           36/14

SD: Standard deviation

Table 2: Number of patients required nitroglycerin

Group        Number of patients
           required nitroglycerin

Group C            40
Group D            00

n=50

Table 3: Grading of bleeding

Grading          Bleeding          Group C   Group D

0            No bleeding              0        10
1            Minimum bleeding        10        40
2            Diffuse bleeding        30         0
3            Considerable,           10         0
             troublesome bleeding

n=50
COPYRIGHT 2018 Dipika Charan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Gohiya, Sarita; Gohiya, Vineet Kumar
Publication:International Journal of Medical Science and Public Health
Article Type:Report
Geographic Code:9INDI
Date:Aug 1, 2018
Words:1795
Previous Article:Comparing lipid profile in healthy participants with and without smoking: A prospective study.
Next Article:Effectiveness of self-instructional module on knowledge and attitude regarding antenatal care among primigravida mothers in selected government...
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters